Therefore, the indirect dual effect of IFN by blocking IL-17 expression (86) and accordingly, reducing neutrophilia and Th17 cells differentiation has been advocated as a rational therapeutic element in the treatment of COVID-19 (106) (Figure 5). Here, IFNA1 is linked to COVID-19.